Brief: Sedana Medical Raises Full-Year Guidance
Oct 24 (Reuters) - Sedana Medical AB (publ) SEDANA.ST :
* RAISES OUR FULL-YEAR FINANCIAL GUIDANCE TO 17-20% NET
SALES
GROWTH
* CLOSING OF INNOVATIF CEKAL ACQUISITION STILL EXPECTED
BEFORE
YEAR END
Source text for Eikon: ID:nMFNYJhb5
Further company coverage: SEDANA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Sedana Medical AB (publ)
See all newsSweden's Sedana Medical Q3 sales rise as growth returns
Brief: Sedana Medical Announces PDUFA Target Action Date
Brief: Sedana Medical Announces FDA Acceptance For Review Of Its New Drug Application In U.S.
Sweden's Sedana Medical Q2 sales flat, EBITDA loss narrows
Brief: Sedana Medical Q2 EBITDA Loss Narrows To SEK 1.9 Mln